IP Library › Granted Patent US 10,195,644
Granted Patent B2
US 10,195,644 · App. 13/766,466 · Granted Feb 5, 2019

Tissue engineering device and construction of vascularized dermis

Inventor: Thomas Boland (El Paso, TX)
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
B05D5/00A61F2/105A61F2240/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,195,644
App. No.
13/766,466
Granted
Feb 5, 2019
Kind
B2
Abstract

An inkjet printing method, system, and computer-usable tangible storage device to print cells and biomaterials for three-dimensional cellular scaffolds and engineered skin grafts are disclosed. The process simultaneously deposits living cells, nutrients, growth factors, therapeutic drugs along with biomaterial scaffolds at the right time and location. This technology can also be used for the microvasculature fabrication using appropriate human microvascular endothelial cells and fibrin to form the microvasculature. When printing human microvascular endothelial cells in conjunction with the fibrin, the cells aligned themselves inside the channels and proliferated to form confluent linings. The 3D tubular structure was also found in the printed patterns. Simultaneously printing biological materials to form a three-dimensional cellular scaffold promotes human microvascular endothelial cell proliferation and microvasculature formation.

Claims (8)

1. An adipose tissue graft, comprising:

a plurality of fibrin channels having endothelial cells aligned inside the fibrin channel, the fibrin channel being surrounded by a matrix comprising adipose cells, fibrinogen, and collagen.

2. The adipose tissue graft of claim 1 , further comprising fibroblasts, interstitial fibroblasts, or adipose tissue-derived stem cells.

3. The adipose tissue graft of claim 1 , further comprising one or more of a nutrient, a growth factor, or a therapeutic drug.

4. The adipose tissue graft of claim 1 , further comprising cells from an autologous or allogenic source.

5. The adipose tissue graft of claim 1 , wherein the endothelial cells are from a lipoaspirate.

6. The adipose tissue graft of claim 5 , wherein the endothelial cells are CD-31 positive endothelial-like cells.

7. The adipose tissue graft of claim 1 , wherein the channels are interconnected and arranged in a grid-like pattern.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2013
From: BOLAND, THOMAS
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 029807/0669 →
Continuity (3)
Provisional Application 61598683 · Feb 14, 2012
Related Publication 20140228970A1 · Aug 14, 2014
Related Publication 20170087590A9 · Mar 30, 2017